ID: ALA1269622

Max Phase: Preclinical

Molecular Formula: C14H12N2O

Molecular Weight: 224.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2oc(Nc3ccccc3)nc2c1

Standard InChI:  InChI=1S/C14H12N2O/c1-10-7-8-13-12(9-10)16-14(17-13)15-11-5-3-2-4-6-11/h2-9H,1H3,(H,15,16)

Standard InChI Key:  SJERMAXXFIXBCQ-UHFFFAOYSA-N

Associated Targets(non-human)

Arachidonate 5-lipoxygenase 121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 224.26Molecular Weight (Monoisotopic): 224.0950AlogP: 3.88#Rotatable Bonds: 2
Polar Surface Area: 38.06Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.01CX Basic pKa: 0.23CX LogP: 3.96CX LogD: 3.96
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.72Np Likeness Score: -1.52

References

1. Song H, Oh SR, Lee HK, Han G, Kim JH, Chang HW, Doh KE, Rhee HK, Choo HY..  (2010)  Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors.,  18  (21): [PMID:20870413] [10.1016/j.bmc.2010.08.047]

Source